SPY468.28+9.49 2.07%
DIA357.74+4.92 1.39%
IXIC15,686.92+461.76 3.03%

BRIEF-Merck Announces Initiation Of Phase 3 Study Evaluating Verquvo

reuters.com · 11/11/2021 06:47
BRIEF-Merck Announces Initiation Of Phase 3 Study Evaluating Verquvo

- Merck & Co Inc MRK:

  • MERCK ANNOUNCES INITIATION OF PHASE 3 STUDY EVALUATING VERQUVO® (VERICIGUAT) IN PATIENTS WITH CHRONIC HEART FAILURE AND REDUCED EJECTION FRACTION WHO HAVE NOT HAD A RECENT WORSENING HEART FAILURE EVENT

Source text for Eikon: ID:nBw5xx8qWa

Further company coverage: MRK


((Reuters.Briefs@thomsonreuters.com;;))